Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Klaria Pharma Holding AB (KLAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8168
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependable transmucosal absorption of clinically established and marketed substances. It also offers reliable and stable supply forms than tablets and other delivery systems such as nasal sprays and orally dissolvable tablets. Klaria Pharma offers its products to customers globally through distributors. The company works in partnership with local pharmaceutical companies on clinical trials, registration, marketing, manufacturing, and others. Klaria Pharma is headquartered in Uppsala, Sweden.

Klaria Pharma Holding AB (KLAR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Klaria Pharma Partners with Recipharm and Clinical Trial Consultants 10
Licensing Agreements 11
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 11
Klaria Pharma Enters into Licensing Agreement with Uppsalagruppen Medical 12
Equity Offering 13
Klaria Pharma Raises USD5.8 Million in Public Offering of Shares 13
Acquisition 14
Klaria Pharma Acquires Klaria AB for USD15.2 Million 14
Klaria Pharma Holding AB – Key Competitors 15
Klaria Pharma Holding AB – Key Employees 16
Klaria Pharma Holding AB – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klaria Pharma Holding AB, Deals By Therapy Area, 2012 to YTD 2018 8
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Klaria Pharma Partners with Recipharm and Clinical Trial Consultants 10
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 11
Klaria Pharma Enters into Licensing Agreement with Uppsalagruppen Medical 12
Klaria Pharma Raises USD5.8 Million in Public Offering of Shares 13
Klaria Pharma Acquires Klaria AB for USD15.2 Million 14
Klaria Pharma Holding AB, Key Competitors 15
Klaria Pharma Holding AB, Key Employees 16
Klaria Pharma Holding AB, Subsidiaries 17

List of Figures
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Phylogica Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary Phylogica Ltd (Phylogica) is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and peptides. Phylogica …
  • Wacker Chemie AG (WCH):電力:M&Aディール及び事業提携情報
    Summary Wacker Chemie AG (Wacker) develops, manufactures and markets various chemical and semiconductor materials. It offers a range of silicone fluids and emulsions, resins, elastomers, sealants and silanes. The company manufactures binders and polymeric additives such as dispersible polymer powder …
  • Ichor Medical Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ichor Medical Systems Inc (Ichor) is a medical equipment company that commercializes electroporation technology for the delivery of vaccines and DNA drugs. The company electroporation technology is used for the treatment and prevention of debilitating diseases. Its trigrid provides DNA drugs …
  • Nippon Telegraph and Telephone Corp (9432):企業の財務・戦略的SWOT分析
    Nippon Telegraph and Telephone Corp (9432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • CCL Industries Inc.:企業のM&A・事業提携・投資動向
    CCL Industries Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CCL Industries Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Andersen Construction Company:企業の戦略的SWOT分析
    Andersen Construction Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Visonic Ltd.:企業の戦略的SWOT分析
    Visonic Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務情報
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Advanced Energy Industries, Inc. (AEIS)-エネルギー分野:企業M&A・提携分析
    Summary Advanced Energy Industries, Inc. (Advanced Energy) is a provider of power conversion, measurement and control solutions. The company designs, manufactures, sells, and supports power conversion products and solutions. These products are used in various applications ranging from manufacturing …
  • Bank Of Panhsin:企業の戦略・SWOT・財務分析
    Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Arab National Bank:企業の戦略・SWOT・財務情報
    Arab National Bank - Strategy, SWOT and Corporate Finance Report Summary Arab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ecrins Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company provides products such as native and labeled tubulin, tubulin polymerization kit and monoclo …
  • Tradewinds Corporation Berhad:企業の戦略・SWOT・財務情報
    Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • SOGLASIE Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Yomeishu Seizo Co Ltd (2540):企業の財務・戦略的SWOT分析
    Yomeishu Seizo Co Ltd (2540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Aeroport Anapa OAO:戦略・SWOT・企業財務分析
    Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • HESTA Super Fund:企業の戦略的SWOT分析
    HESTA Super Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆